GlassScriptPhysician profile
Raj K Mulpuri
NPI 1669460853
$14,400.77
in general payments reported to CMS, 2019-2025
55 companies · $3,183 in 2025
The $3,183 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,681 · 2020: $1,279 · 2021: $1,873 · 2022: $2,028 · 2023: $2,096 · 2024: $2,262 · 2025: $3,183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,295 · Education: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,295.35 |
| Education | $245.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,168.73 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,930.28 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,656.04 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Mylan Specialty L.P. | $1,079.37 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $593.77 | 2020-2024 | Wakix |
| Insmed, INC. | $515.69 | 2020-2025 | Arikayce, Brinsupri |
| Electromed, INC. | $500.88 | 2019-2025 | Smartvest |
| Genentech USA, INC. | $460.76 | 2019-2025 | Xolair |
| Actelion Pharmaceuticals US, INC. | $415.20 | 2019-2024 | Opsumit, Uptravi |
| Genzyme Corporation | $375.44 | 2019-2025 | |
| Philips North America LLC | $334.25 | 2019-2025 | (Di7) Home Pi Undivided, Dreamwear, Vest Therapy Und |
| Baxter Healthcare | $325.33 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $273.94 | 2020-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $262.17 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $251.06 | 2019-2023 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $219.70 | 2025 | Ohtuvayre |
| Grifols USA, LLC | $217.21 | 2022-2025 | Xembify, Gamunex-C |
| Viatris Specialty LLC | $207.59 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $199.14 | 2024-2025 | Zerbaxa, Winrevair |
| Pulmonx Corporation | $194.52 | 2019-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Advanced Respiratory, INC | $162.91 | 2019-2021 | |
| Penumbra, INC. | $157.82 | 2022 | |
| Ani Pharmaceuticals, INC. | $153.92 | 2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $127.56 | 2019-2025 | |
| Inari Medical, INC. | $125.73 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mallinckrodt Hospital Products INC. | $120.52 | 2021-2023 | Acthar |
| Inogen, INC. | $107.83 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Inspire Medical Systems, INC. | $106.05 | 2023-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $104.92 | 2023-2025 | Lumryz |
| Sunovion Pharmaceuticals INC. | $103.04 | 2019-2020 | |
| Medtronic, INC. | $99.93 | 2024 | Kyphon Express II Kyphopak Tray |
| Pfizer INC. | $94.06 | 2019-2023 | |
| Abbott Laboratories | $80.61 | 2019-2023 | Gallant, Mitraclip |
| United Therapeutics Corporation | $75.41 | 2021-2025 | Tyvaso |
| Amarin Pharma, INC. | $61.44 | 2020-2021 | |
| Axsome Therapeutics, INC. | $60.71 | 2024-2025 | Sunosi |
| Amgen INC. | $56.78 | 2019-2025 | Tezspire |
| Paratek Pharmaceuticals, INC. | $50.19 | 2021-2023 | Nuzyra |
| Circassia INC. | $43.22 | 2019-2020 | |
| Shire North American Group INC | $39.22 | 2019 | |
| Edwards Lifesciences Corporation | $32.91 | 2022 | |
| Pharming Healthcare, INC. | $28.46 | 2024 | Ruconest |
| Zoll Respicardia, INC. | $23.52 | 2024 | Remede System |
| Ethicon INC. | $22.99 | 2022 | |
| Boston Scientific Corporation | $20.33 | 2024 | |
| Allergan, INC. | $19.84 | 2019 | |
| Phadia US INC. | $19.47 | 2024 | Immunocap |
| Seqirus USA INC | $18.86 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.05 | 2023 | |
| Nabriva Therapeutics, Plc | $16.29 | 2020 | |
| Janssen Pharmaceuticals, INC | $15.18 | 2022 | |
| Medtronic USA, INC. | $14.92 | 2019 | |
| Apria Healthcare LLC | $13.49 | 2021 | |
| Alfasigma USA, INC. | $12.17 | 2020 | |
| Ucb, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Mulpuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.